Extrahepatic vitelline vein aneurysm: prenatal diagnosis and follow up

Hery, G.; Quarello, E.; Gorincour, Guillaume; Franchi, S.; Gauthier, F.

doi:10.1016/j.jpedsurg.2013.06.007

Cited by 13 publications

(25 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One older case study from 1998 was incorporated because of the unique, descriptive information provided, resulting in a total of 72 available publications for data assessment. Following critical appraisal of the resources and selection criteria, 19 were retained (Table ) . All of the publications over the 19 years were case reports or case series.…”

Section: Resultsmentioning

confidence: 99%

“…The key long‐term outcomes from neonatal PVT that result in morbidity and mortality are liver lobe atrophy, portal hypertension, esophageal varices, portal collaterals, and cavernoma . The incidence of these findings is dependent totally on the duration of follow‐up.…”

Section: Discussionmentioning

confidence: 99%

“…at six years, and Hery et al. at nine years . Similarly, the rest of the documented outcomes and their respective long‐term prognoses will show a wide variation, because none of the studies evaluated outcomes prospectively based on predetermined time intervals.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy

Bhatt

Patel

Butt

et al. 2018

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Background Neonatal portal vein thrombosis (PVT) is uncommon with potentially serious complications that may manifest in infancy and childhood. Objective The primary aim of our study was to describe the short‐term and long‐term outcomes of neonatal PVT. Methods A retrospective chart review was conducted from 2008 to 2016 of neonates diagnosed with PVT. A systematic review was also performed from 2000 to 2018 to evaluate anticoagulant therapy (ACT) in neonatal PVT. Results Forty‐four premature and 30 term infants (mean gestational age 30.7 vs 39.1 weeks, respectively) had PVT. Sixty‐eight involved the left portal vein, one involved only the main portal vein, and 5 involved ≥1 vein. PVT was catheter associated in 46 (62%); none of the 7 neonates tested had thrombophilia. Of 74 neonates, 19 (26%) received ACT and 55 (74%) were untreated. The mean follow‐up duration was 16.6 months (SD = 17.62; range, 0–89.6); 59.5% were followed for ≥6 months. On last ultrasound examination, thrombus resolution was documented in treated (ACT; n = 19) and nontreated (n = 55) neonates: 12 (63%) versus 32 (58%) with complete resolution, 1 (5%) versus 6 (11%) partial, 0 versus 1 (2%) extension, and 6 (32%) versus 16 (29%) had nonprogressive lesions, respectively. Seventy‐one (96%) had no complications. Seventy‐one articles met inclusion criteria for the systematic review and 19 were retained for analysis after assessment. Conclusions PVT resolution rate was similar to previous reports. Although a low complication rate was detected, longer follow‐up is necessary to determine the need for early treatment and the precise incidence of outcomes such as portal hypertension.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy

Bhatt

Patel

Butt

et al. 2018

Pediatric Blood & Cancer

View full text Add to dashboard Cite

show abstract

“…Eight cases of persistent VV have been described previously in the literature. In all eight, the definitive diagnosis was made after birth, the presence of a thrombotic mass in the portal system being the main reason for the diagnostic workup. In four of them there was no prenatal diagnosis; three of these cases were diagnosed incidentally at postmortem examination.…”

Section: Discussionmentioning

confidence: 99%

“…Although persistence of the vitelline veins (VV) has been described, and classified by Blackburn as a type‐IV umbilical system anomaly, literature concerning its clinical significance is scarce. Reports include only eight cases, all diagnosed in the postpartum period: four reported by pediatric surgeons, three by a pathologist after intrauterine fetal death and one by radiologists.…”

Section: Introductionmentioning

confidence: 99%

Choriovitelline placenta: prenatal sonographic imaging and clinical characteristics

Achiron

Kivilevitch

2017

Ultrasound Obstet Gynecol

View full text Add to dashboard Cite

show abstract

Prenatal sonographic diagnosis of a vitelline vein aneurysm

Sahinoglu¹,

Çetinkaya²

2018

J of Clinical Ultrasound

View full text Add to dashboard Cite

We report a case of vitelline vein aneurysm detected at 23 weeks of gestation. Few postnatal cases of vitelline vein aneurysm have been reported; however, due to their similar appearances most of them were considered initially as umbilical vein dilatations. The accurate prenatal diagnosis of vitelline vein aneurysm and early postnatal surgical treatment are crucial steps to prevent postnatal obliterative extension of thrombosis that might cause severe neonatal morbidity.

show abstract

Extrahepatic vitelline vein aneurysm: prenatal diagnosis and follow up

Cited by 13 publications

References 8 publications

Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy

Outcomes following neonatal portal vein thrombosis: A descriptive, single‐center study and review of anticoagulant therapy

Choriovitelline placenta: prenatal sonographic imaging and clinical characteristics

Prenatal sonographic diagnosis of a vitelline vein aneurysm

Contact Info

Product

Resources

About